MACH7 TECHNOLOGIES LIMITED — Interim / Quarterly Report 2009

Apr 29, 2009

==> picture [112 x 102] intentionally omitted <==

30 April 2009

ASX and Media Announcement

APPENDIX 4C - Quarterly Report for entities admitted on the basis of commitments

FOR THE QUARTER ENDED 31 MARCH 2009

Highlights:

• New Pureste range being sold by major retail stores and pharmacy groups.

• Marketing campaign to commence in early May 2009.

Pureste

Pureste is an innovative, category-changing range of the first and only sterlised tampons, pads and panty liner products in Australia.

The Pureste range is now available through Woolworths, National Pharmacies and United Discount Pharmacies and will soon be in Kmart, Target, Priceline and other leading groups.

The company has appointed leading brand developer, Creative Brands Pty Ltd (www.creativebrands.com.au) to distribute and market the range through Grocery, Pharmacy, Department, Discount Department, Wholesale, Gift Store and Route Trade Channels.

Established in 1972, Creative Brands has extensive networks and strong relationships with retailers Nationally and Internationally, employing more than 50 staff including an exceptional National sales and Marketing team as well as an additional 200 sales and merchandising specialists through support agencies.

A Nationwide marketing campaign will commence in early May 2009.

Cash at 31 March 2009

Cash and cash equivalents as at 31 March 2009 amounted to $(103,514). The SafetyMed group currently has available finance facilities amounting to $10 million of which $1.9 million has been utilised. Further details of finance facilities are disclosed in the 31 December 2008 Interim Financial Report’s Note 9 (pages 15 to 16).

About Safety Medical Products Limited

SafetyMed is a company focused on developing and marketing a unique range of innovative Safety Products led by its flagship SecureTouch Retractable Syringe.

About the ‘Pureste’ feminine hygiene product range

SafetyMed, via its 50% owned subsidiary, Pureste Pty Ltd ( ‘Pureste’ ) has developed the first and only range of sterilised tampons, pads and panty liners to be marketed and distributed across Australia and New Zealand through leading retail outlets and pharmacies.

Further information of the Pureste product range please visit: www.pureste.com.au.

For further information please contact:

Mr. John Riemelmoser Managing Director Safety Medical Products Limited Ph (08) 8285 5226 Fax (08) 8285 3228 Email info@safetymed.com.au

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Appendix 4C

Quarterly report for entities admitted on the basis of commitments

Introduced 31/3/2000. Amended 30/9/2001, 24/10/2005.

Name of entity

Safety Medical Products Limited

ABN 26 007 817 192

Quarter ended (“current quarter”) 31 March 2009

Consolidated statement of cash flows

Consolidated statement of cash flows
Cash flows related to operating activities 1.1 Receipts from customers 1.2 Payments for (a) staff costs (b) advertising and marketing (c) research and development (d) leased assets (e) other working capital 1.3 Dividends received 1.4 Interest and other items of a similar nature received 1.5 Interest and other costs of finance paid 1.6 Income taxes 1.7 Other (provide details if material) Direct purchases Accounting & auditing Patent & Trade Mark expenses Property rental & outgoings Consulting fees Travel Share Registry & ASX expenses Net operating cash flows	Current quarter $A’000	Year to date (9 months) $A’000
	1,204 (670) (158) - (2) (321) - 1 (14) (6) (846) (90) (6) (68) (44) (7) (7)	4,041 (1,903) (255) - (4) (753) - 4 (100) 24 (2,085) (142) (16) (176) (132) (31) (38)
	(1,034)	(1,566)

• See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 1

	Current quarter $A’000	Year to date (9 months) $A’000
1.8 Net operating cash flows (carried forward)	(1,034)	(1,566)
Cash flows related to investing activities 1.9 Payment for acquisition of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non-current assets (e) other non-current assets 1.10 Proceeds from disposal of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non-current assets (e) other non-current assets 1.11 Loans to other entities 1.12 Loans repaid by other entities 1.13 Other (Stamp Duty paid following acquisition of Bagot Press. Acquisition closed 1 May 2007) Net investing cash flows 1.14 Total operating and investing cash flows	- - - (3) - - - - - - - - -	- - - (62) - - - - 23 - - - -
	(3)	(39)
	(1,037)	(1,605)
Cash flows related to financing activities 1.15 Proceeds from issues of shares, options, etc. 1.16 Proceeds from sale of forfeited shares 1.17 Proceeds from borrowings 1.18 Repayment of borrowings 1.19 Dividends paid 1.20 Other (provide details if material) Net financing cash flows	- - 672 (27) - -	225 - 1,130 (108) - (28)
	645	1,219
Net increase (decrease) in cash held 1.21 Cash at beginning of quarter/year to date 1.22 Exchange rate adjustments to item 1.20 1.23 Cash at end of quarter	(392) 289 -	(386) 283 -
	(103)	(103)

Payments to directors of the entity and associates of the directors

Payments to related entities of the entity and associates of the related entities

1.24 Aggregate amount of payments to the parties included in item 1.2 1.25 Aggregate amount of loans to the parties included in item 1.11	Current quarter $A'000
	50
	-

• 1.26 Explanation necessary for an understanding of the transactions

Consists of director fees, salaries and superannuation to directors, and consulting fees paid to director-related entities.

Non-cash financing and investing activities

• 2.1 Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows

Not Applicable

• 2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

Not Applicable

Financing facilities available

Financing facilities available
3.1 Loan facilities 3.2 Credit standby arrangements	Amount available $A’000	Amount used $A’000
	1,516	1,516
	8,540	401

• 3.1 Loan facilities exclude Convertibles Notes of $775,000 at 31 March 2009.

• 3.2 Credit standby facilities include bank overdraft facilities, trade finance facilities and the documentary letter of credit facility.

Reconciliation of cash

Reconciliation of cash
Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows.	Current quarter $A’000	Previous quarter $A’000
4.1 Cash on hand and at bank 4.2 Deposits at call 4.3 Bank overdraft 4.4 Other (provide details)	226	289
	-	-
	(329)	-
	-	-
Total: cash at end of quarter(item 1.23)	(103)	289

Acquisitions and disposals of business entities

5.1 Name of entity 5.2 Place of incorporation or registration 5.3 Consideration for acquisition or disposal 5.4 Total net assets 5.5 Nature of business	Acquisitions (Item 1.9(a))	Disposals (Item 1.10(a))
	Not Applicable	Not Applicable

Compliance statement

• 1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.

• 2 This statement does give a true and fair view of the matters disclosed.

Sign here: Date: 30 April 2009 (Director)

Print name: John Riemelmoser

Notes

1. The quarterly report provides a basis for informing the market how the entity’s activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.

2. The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below.

3. 6.2 - reconciliation of cash flows arising from operating activities to operating profit or loss

4. 9.2 - itemised disclosure relating to acquisitions

5. 9.4 - itemised disclosure relating to disposals  12.1(a) - policy for classification of cash items  12.3 - disclosure of restrictions on use of cash  13.1 - comparative information

6. Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.